Prime Minister Narendra Modi chaired the 54th PRAGATI meeting to evaluate infrastructure projects worth over Rs 16,000 crore. The meeting f...

When a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...

Advent International has successfully raised $30 billion for its global buyout and mid-market funds. The firm plans to invest significantly...

At this juncture, what companies say about their Q2 results, and their outlook for Q3 and Q4, matters a great deal – but only to a certain ...

Dr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...

Those who have been following the market for long know this: When there is nervousness on the street, money instinctively moves towards a p...

Indian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...

A piece of advice for those who still have the stomach to invest in the current volatile market. Don’t take any price action as the gospel ...

Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...

Scaling too fast is irrelevant. The real problem is that India still confuses more hospitals, more doctors and more medicines with better h...

GST Council Meeting 2026: The GST Council, meeting in New Delhi, is expected to propose significant reforms for tax administration. One ref...

Maharashtra's Food and Drug Administration has cancelled Cipla Pharma's distribution licenses due to serious violations. The FDA discovered...

Nifty valuations have reset sharply from 2024 levels and are now near post-Covid lows, says Alchemy Capital’s Alok Agarwal. He sees the nex...

Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...

For decades, there was a familiar way to understand the Indian consumer. Economists waited for GDP, industrial production, inflation, credi...

Former FSSAI chief Pawan Kumar Agarwal has urged the Supreme Court to consider a phased rollout of front-of-pack food warnings, warning tha...

FDA Commissioner Tukaram Mundhe faces criticism after initial praise for regulatory actions. The Bombay High Court has repeatedly pulled up...